Literature DB >> 2693341

[Serodiagnosis of Lyme borreliosis: antibody titer and specificity in the IFT and western blot].

W Grellner1, F Erbguth, V Brade.   

Abstract

Out of 334 sera from healthy persons from northern Bavaria 6% reacted positive in the indirect immunofluorescence test (IFT, titre greater than or equal to 1:64). The percentage of positive cases in patients with erythema chronicum migrans (ECM), meningoradiculitis (M. Bannwarth), or acrodermatitis chronica atrophicans (ACA) was 43, 83 and 78%, respectively. In other patients with less characteristic symptoms in which an infection with B. burgdorferi was suspected the number of positive cases was only about 20%. A positive IgM-IFT was most often associated with ECM and M. Bannwarth; however, even in these cases IgM was only found in 30%. The serodiagnosis of Lyme disease required simultaneous serum testing of T. pallidum antibodies (TPHA) to exclude a syphilis with cross-reacting antibodies. In cases with a positive B. burgdorferi-IFT and TPHA the final diagnosis of Lyme disease was possible on the basis of Western blot analysis. The prominent antigens detected by sera from patients with Lyme disease--but not with syphilis--had molecular weights of 18, 22, 41 and 60 K; IgM antibodies were mainly directed against the 22 K and 41 K antigens. The antigen pattern was not characteristic for different disease stages.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2693341

Source DB:  PubMed          Journal:  Immun Infekt


  5 in total

1.  Coiling phagocytosis is the preferential phagocytic mechanism for Borrelia burgdorferi.

Authors:  M G Rittig; A Krause; T Häupl; U E Schaible; M Modolell; M D Kramer; E Lütjen-Drecoll; M M Simon; G R Burmester
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

2.  Evaluation of a passive hemagglutination assay as screening test and of a recombinant immunoblot as confirmatory test for serological diagnosis of Lyme disease.

Authors:  A Hamann-Brand; M Flondor; V Brade
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-07       Impact factor: 3.267

3.  Cellular immune reactivity to recombinant OspA and flagellin from Borrelia burgdorferi in patients with Lyme borreliosis. Complexity of humoral and cellular immune responses.

Authors:  A Krause; G R Burmester; A Rensing; C Schoerner; U E Schaible; M M Simon; P Herzer; M D Kramer; R Wallich
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

4.  Immunological and molecular polymorphisms of OspC, an immunodominant major outer surface protein of Borrelia burgdorferi.

Authors:  B Wilske; V Preac-Mursic; S Jauris; A Hofmann; I Pradel; E Soutschek; E Schwab; G Will; G Wanner
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

5.  Facial palsy with elevated protein in otherwise normal CSF in a child with Lyme disease.

Authors:  U Heininger; M Ries; D Harms; V Brade
Journal:  Infection       Date:  1991 Jul-Aug       Impact factor: 3.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.